TapewireFind a company

person · Reporting owner

ICAHN BRETT

Disclosed activity across 8 companies

Tapewire entity
38620
SEC CIK
0001387184

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Bausch & Lomb CorpBLCO · Entity 3756DirectorMay 27, 2025May 28, 2025
Bausch Health Companies Inc.BHC · Entity 4363DirectorJune 30, 2025July 02, 2025
CVR ENERGY INCCVI · Entity 4008DirectorAugust 01, 2025August 07, 2025
DANA IncDAN · Entity 6DirectorMay 30, 2025June 02, 2025
ICAHN ENTERPRISES L.P.IEP · Entity 3928DirectorSeptember 30, 2024October 02, 2024
INTERNATIONAL FLAVORS & FRAGRANCES INCIFF · Entity 3234DirectorMay 01, 2026May 04, 2026
NEWELL BRANDS INC.NWL · Entity 4339DirectorFebruary 16, 2023February 21, 2023
SANDRIDGE ENERGY INCSD · Entity 2054DirectorJune 10, 2026June 12, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Bausch & Lomb Corp

Report date May 27, 2025 · Filed May 28, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Shares, No Par ValueSEC Table I · non-derivativeDirect61,147 Reported balance After 2025-05-27 transaction · row 1
1 source row

Row 1 · 2025-05-27 · Grant · Acquired 20,338 · Balance 61,147

F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders.

Bausch Health Companies Inc.

Report date June 30, 2025 · Filed July 02, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Shares, No Par ValueSEC Table I · non-derivativeDirect220,280 Reported balance After 2025-06-30 transaction · row 1
1 source row

Row 1 · 2025-06-30 · Grant · Acquired 4,034 · Balance 220,280

F1: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer.

CVR ENERGY INC

Report date August 01, 2025 · Filed August 07, 2025

This filing explicitly reported no securities owned.

DANA Inc

Report date May 30, 2025 · Filed June 02, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect132 Reported balance After 2025-05-30 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2025-05-30 · Grant · Acquired 61 · Balance 132

F1: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

Filing footnotes · ownership attribution and instrument terms

F1: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

ICAHN ENTERPRISES L.P.

Report date September 30, 2024 · Filed October 02, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Depository UnitsSEC Table I · non-derivativeDirect345,761 Reported balance After 2024-09-30 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2024-09-30 · Tax withholding · Disposed 34,179 · Balance 345,761

F1: Depositary Units representing limited partner interests in Icahn Enterprises L.P.

F2: Represents the withholding of Depositary Units to satisfy the Reporting Person's tax obligations in connection with the vesting of restricted Depositary Units and accrued dividends. The Reporting Person was granted 239,254 restricted Depositary Units on October 1, 2020 under the Icahn Enterprises L.P. 2017 Long-Term Incentive Plan. 34,179 Depositary Units vested on September 30, 2024

Filing footnotes · ownership attribution and instrument terms

F1: Depositary Units representing limited partner interests in Icahn Enterprises L.P.

F2: Represents the withholding of Depositary Units to satisfy the Reporting Person's tax obligations in connection with the vesting of restricted Depositary Units and accrued dividends. The Reporting Person was granted 239,254 restricted Depositary Units on October 1, 2020 under the Icahn Enterprises L.P. 2017 Long-Term Incentive Plan. 34,179 Depositary Units vested on September 30, 2024

INTERNATIONAL FLAVORS & FRAGRANCES INC

Report date May 01, 2026 · Filed May 04, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect34,712 Reported balance After 2026-05-01 transaction · row 1
1 source row

Row 1 · 2026-05-01 · Exercise / conversion · Acquired 1,712 · Balance 34,712

F1: Represent RSUs granted under the Non-Employee Director Compensation Program.

F2: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect0 Reported balance After 2026-05-01 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-05-01 · Exercise / conversion · Disposed 1,712 · Balance 0

F2: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F1: Represent RSUs granted under the Non-Employee Director Compensation Program.

F3: On November 3, 2025, the reporting person was granted 1,712 restricted stock units, all of which vested on May 1, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Represent RSUs granted under the Non-Employee Director Compensation Program.

F2: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F3: On November 3, 2025, the reporting person was granted 1,712 restricted stock units, all of which vested on May 1, 2026.

NEWELL BRANDS INC.

Report date February 16, 2023 · Filed February 21, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect471,003 Ending reported balance After 2023-02-17 transaction · row 3
2 source rows · reconciled sequence

Row 1 · 2023-02-16 · Sale · Disposed 107,372 · Balance 845,631

F1: The price reported is a weighted average stock price. Shares were sold between $15.29 and $15.50, inclusive.

Row 3 · 2023-02-17 · Sale · Disposed 374,628 · Balance 471,003

F2: The price reported is a weighted average stock price. Shares were sold between $14.77 and $15.18, inclusive.

Common StockSEC Table I · non-derivativeIndirectCharitable Foundation213,714 Reported balance After 2023-02-16 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 2 · 2023-02-16 · Sale · Disposed 26,286 · Balance 213,714

F1: The price reported is a weighted average stock price. Shares were sold between $15.29 and $15.50, inclusive.

Common StockSEC Table I · non-derivativeIndirectCharitable Foundation122,000 Reported balance After 2023-02-17 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 4 · 2023-02-17 · Sale · Disposed 91,714 · Balance 122,000

F2: The price reported is a weighted average stock price. Shares were sold between $14.77 and $15.18, inclusive.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported is a weighted average stock price. Shares were sold between $15.29 and $15.50, inclusive.

F2: The price reported is a weighted average stock price. Shares were sold between $14.77 and $15.18, inclusive.

SANDRIDGE ENERGY INC

Report date June 10, 2026 · Filed June 12, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect22,709 Reported balance After 2026-06-10 transaction · row 1
1 source row

Row 1 · 2026-06-10 · Grant · Acquired 9,804 · Balance 22,709

F1: Reflects shares of restricted stock granted on June 10, 2026, which will vest on the earlier of the first anniversary of the grant date or the day immediately preceding the Company's next annual meeting of stockholders.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects shares of restricted stock granted on June 10, 2026, which will vest on the earlier of the first anniversary of the grant date or the day immediately preceding the Company's next annual meeting of stockholders.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 10, 2026 Filed Jun 12, 2026 20:31 UTC SANDRIDGE ENERGY INC SD · Entity 2054 GrantCommon Stock 9,804 $15.30 $150,001.20
Disclosure

SEC source: 0001387184-26-000003 · primarydocument.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,709

F1 · shares: Reflects shares of restricted stock granted on June 10, 2026, which will vest on the earlier of the first anniversary of the grant date or the day immediately preceding the Company's next annual meeting of stockholders.

Read SEC document
May 01, 2026 Filed May 4, 2026 21:09 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 Exercise / conversionRestricted Stock Units · Derivative 1,712 $70.81 $121,226.72
Disclosure

SEC source: 0001225208-26-004882 · doc4.xml · derivative · entry 2

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,712 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F1 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program.

F3 · derivative.exercise_date: On November 3, 2025, the reporting person was granted 1,712 restricted stock units, all of which vested on May 1, 2026.

F3 · derivative.expiration_date: On November 3, 2025, the reporting person was granted 1,712 restricted stock units, all of which vested on May 1, 2026.

Read SEC document
May 01, 2026 Filed May 4, 2026 21:09 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 Exercise / conversionCommon Stock 1,712 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-004882 · doc4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,712

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program.

F2 · price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

Read SEC document
April 29, 2026 Filed Apr 30, 2026 20:29 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 GrantRestricted Stock Units · Derivative 2,903 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-004736 · doc4.xml · derivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,903

Underlying: Common Stock · 2,903 shares

Expires 2027-04-29

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program.

F3 · derivative.exercise_date: The RSUs will vest on the one-year anniversary of the grant date.

F3 · derivative.expiration_date: The RSUs will vest on the one-year anniversary of the grant date.

Read SEC document
November 11, 2025 Filed Nov 12, 2025 22:17 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 GrantCommon Stock 13,000 $64.44 $837,749.90
Disclosure

SEC source: 0001225208-25-009120 · doc4.xml · nonDerivative · entry 2

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,000

F2 · price: Weighted average price. These shares were purchased in multiple transactions at prices ranging from $63.19 to $65.31 inclusive. The reporting person undertakes to provide to the issuer, any security holder of theissuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
November 10, 2025 Filed Nov 12, 2025 22:17 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 GrantCommon Stock 20,000 $62.96 $1,259,218.00
Disclosure

SEC source: 0001225208-25-009120 · doc4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

F1 · price: Weighted average price. These shares were purchased in multiple transactions at prices ranging from $62.65 to $63.43 inclusive. The reporting person undertakes to provide to the issuer, any security holder of theissuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Read SEC document
November 03, 2025 Filed Nov 4, 2025 21:21 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 GrantRestricted Stock Units · Derivative 1,712 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008914 · doc4.xml · derivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,712

Underlying: Common Stock · 1,712 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2 · derivative.expiration_date: The RSUs will vest on May 1, 2026.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 20:38 UTC SANDRIDGE ENERGY INC SD · Entity 2054 GrantCommon Stock, par value $0.001 per share 12,905 $10.00 $129,050.00
Disclosure

SEC source: 0001213900-25-072134 · ownership.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,905

F1 · security: Reflects shares of restricted stock granted on August 1, 2025 which will vest on the earlier of the first anniversary of the grant date or the day immediately preceding the Company's next annual meeting of stockholders.

Read SEC document
June 30, 2025 Filed Jul 2, 2025 20:38 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 4,034 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-018673 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,280

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer.

Read SEC document
May 30, 2025 Filed Jun 2, 2025 20:20 UTC DANA Inc DAN · Entity 6 GrantDividend Equivalent Rights · Derivative 61 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-005597 · doc4.xml · derivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132

Underlying: Common Stock, par value $0.01 · 61 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

Read SEC document
May 27, 2025 Filed May 28, 2025 20:04 UTC Bausch & Lomb Corp BLCO · Entity 3756 GrantCommon Shares, No Par Value 20,338 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-015801 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,147

F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders.

Read SEC document
May 16, 2025 Filed May 20, 2025 20:38 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 54,347 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-015040 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,246

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
March 31, 2025 Filed Apr 1, 2025 20:35 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 5,119 $6.47 $33,119.93
Disclosure

SEC source: 0001127602-25-010796 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,899

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer.

Read SEC document
March 21, 2025 Filed Mar 21, 2025 20:53 UTC DANA Inc DAN · Entity 6 GrantDividend Equivalent Rights · Derivative 71 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-003573 · doc4.xml · derivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71

Underlying: Common Stock, par value $0.01 · 71 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

Read SEC document
February 11, 2025 Filed Feb 13, 2025 21:25 UTC DANA Inc DAN · Entity 6 GrantRestricted Stock Units · Derivative 10,104 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-001670 · doc4.xml · derivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,104

Underlying: Common Stock, par value $0.01 · 10,104 shares

Expires not disclosed

F1 · security: Restricted stock units granted pursuant to the Dana Incorporated 2021 Omnibus Incentive Plan.

F2 · derivative.exercise_price: Each restricted stock unit granted represents the right to receive one share of Dana common stock or, at the election of Dana, cash equal to the market value per share. Each restricted stock unit contains dividend equivalent rights.

F3 · derivative.exercise_date: Restricted stock units granted vest in full on the first anniversary date of the grant.

F3 · derivative.expiration_date: Restricted stock units granted vest in full on the first anniversary date of the grant.

Read SEC document
December 31, 2024 Filed Jan 2, 2025 12:50 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 4,109 $8.06 $33,118.54
Disclosure

SEC source: 0001127602-25-000001 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,780

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2024, each representing a contingent right to receive one common share, no par value, of the Issuer.

Read SEC document
September 30, 2024 Filed Oct 1, 2024 20:16 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 4,059 $8.16 $33,121.44
Disclosure

SEC source: 0001127602-24-024688 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,671

F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2024, each representing a contingent right to receive one common share, no par value, of the Issuer.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 21:31 UTC ICAHN ENTERPRISES L.P. IEP · Entity 3928 Tax withholdingDepository Units 34,179 $13.37 $456,973.23
Disclosure

SEC source: 0001062993-24-017300 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 345,761

F1 · security: Depositary Units representing limited partner interests in Icahn Enterprises L.P.

F2 · kind: Represents the withholding of Depositary Units to satisfy the Reporting Person's tax obligations in connection with the vesting of restricted Depositary Units and accrued dividends. The Reporting Person was granted 239,254 restricted Depositary Units on October 1, 2020 under the Icahn Enterprises L.P. 2017 Long-Term Incentive Plan. 34,179 Depositary Units vested on September 30, 2024

Read SEC document
August 02, 2024 Filed Aug 6, 2024 21:52 UTC Bausch & Lomb Corp BLCO · Entity 3756 GrantCommon Shares, No Par Value 14,696 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-021755 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,809

F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders.

Read SEC document
June 28, 2024 Filed Jul 1, 2024 20:46 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 4,752 $6.97 $33,121.44
Disclosure

SEC source: 0001127602-24-019573 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,612

F1 · shares: Reflects Restricted Share Units issued?in?lieu?of?cash?compensation?in?connection with the Reporting Person's service on the Issuer's Board?of?Directors for the quarter ending June 30, 2024, each representing a contingent right to receive one common share, no par value, of the Issuer.

Read SEC document
May 17, 2024 Filed May 20, 2024 21:43 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 35,360 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-016023 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,860

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
March 29, 2024 Filed Apr 1, 2024 20:31 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 3,122 $10.61 $33,124.42
Disclosure

SEC source: 0001127602-24-011594 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,500

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
December 29, 2023 Filed Jan 2, 2024 21:18 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 4,130 $8.02 $33,122.60
Disclosure

SEC source: 0001127602-24-000128 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,378

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
September 30, 2023 Filed Oct 3, 2023 21:15 UTC ICAHN ENTERPRISES L.P. IEP · Entity 3928 Tax withholdingDepositary Units 29,206 $20.15 $588,448.33
Disclosure

SEC source: 0001539497-23-001679 · ownership.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 379,940

F1 · security: Depositary Units representing limited partner interests in Icahn Enterprises L.P.

F2 · kind: Represents the withholding of Depositary Units to satisfy the Reporting Person's tax obligations in connection with the vesting of restricted Depositary Units and accrued dividends. The Reporting Person was granted 239,254 restricted Depositary Units on October 1, 2020 under the Icahn Enterprises L.P. 2017 Long-Term Incentive Plan. 34,179 Depositary Units vested on September 30, 2023.

F3 · balance_after: Includes 742 Depositary Units previously received by the Reporting Person as a payment-in-kind dividend in a transaction exempt from Section 16(a) and Section 16(b) liability pursuant to Rule 16a-9(a) and Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended, which were inadvertently excluded from the aggregate ownership amount in prior filings.

Read SEC document
September 29, 2023 Filed Oct 2, 2023 20:25 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 4,029 $8.22 $33,118.38
Disclosure

SEC source: 0001127602-23-025001 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,248

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
September 01, 2023 Filed Sep 5, 2023 20:39 UTC DANA Inc DAN · Entity 6 GrantDividend Equivalent Rights · Derivative 49 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-008690 · doc4.xml · derivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164

Underlying: Common Stock, par value $0.01 · 49 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

Read SEC document
June 30, 2023 Filed Jul 5, 2023 20:07 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 4,140 $8.00 $33,120.00
Disclosure

SEC source: 0001127602-23-020001 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,219

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 20:40 UTC DANA Inc DAN · Entity 6 GrantDividend Equivalent Rights · Derivative 57 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-006600 · doc4.xml · derivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115

Underlying: Common Stock, par value $0.01 · 57 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

Read SEC document
May 19, 2023 Filed May 19, 2023 20:11 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 29,205 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016281 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,079

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
May 04, 2023 Filed May 5, 2023 20:24 UTC Bausch & Lomb Corp BLCO · Entity 3756 GrantCommon Shares, No Par Value 12,857 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-014696 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,113

F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 22:03 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 3,684 $8.10 $29,840.40
Disclosure

SEC source: 0001127602-23-012410 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,874

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
March 24, 2023 Filed Mar 28, 2023 20:36 UTC DANA Inc DAN · Entity 6 GrantDividend Equivalent Rights · Derivative 58 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-004286 · doc4.xml · derivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58

Underlying: Common Stock, par value $0.01 · 58 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 21:14 UTC NEWELL BRANDS INC. NWL · Entity 4339 SaleCommon Stock 91,714 $14.95 $1,371,124.30
Disclosure

SEC source: 0000814453-23-000028 · wf-form4_167701404377021.xml · nonDerivative · entry 4

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Charitable Foundation

Disclosed balance after: 122,000

F2 · price: The price reported is a weighted average stock price. Shares were sold between $14.77 and $15.18, inclusive.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 21:14 UTC NEWELL BRANDS INC. NWL · Entity 4339 SaleCommon Stock 374,628 $14.95 $5,600,688.60
Disclosure

SEC source: 0000814453-23-000028 · wf-form4_167701404377021.xml · nonDerivative · entry 3

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 471,003

F2 · price: The price reported is a weighted average stock price. Shares were sold between $14.77 and $15.18, inclusive.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 21:42 UTC DANA Inc DAN · Entity 6 Exercise / conversionRestricted Stock Units · Derivative 6,578 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-002410 · doc4.xml · derivative · entry 4

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $0.01 · 6,578 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit granted represents the right to receive one share of Dana common stock or, at the election of Dana, cash equal to the market value per share. Each restricted stock unit contains dividend equivalent rights.

F3 · derivative.exercise_date: Restricted stock units granted vest in full on the first anniversary date of the grant.

F3 · derivative.expiration_date: Restricted stock units granted vest in full on the first anniversary date of the grant.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 21:42 UTC DANA Inc DAN · Entity 6 Exercise / conversionDividend Equivalent Rights · Derivative 159 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-002410 · doc4.xml · derivative · entry 3

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $0.01 · 159 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate, which have vested.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate, which have vested.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate, which have vested.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 21:42 UTC DANA Inc DAN · Entity 6 Exercise / conversionCommon Stock, par value $0.01 159 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-002410 · doc4.xml · nonDerivative · entry 2

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,737

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 21:42 UTC DANA Inc DAN · Entity 6 Exercise / conversionCommon Stock, par value $0.01 6,578 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-002410 · doc4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,578

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 21:14 UTC NEWELL BRANDS INC. NWL · Entity 4339 SaleCommon Stock 26,286 $15.37 $404,015.82
Disclosure

SEC source: 0000814453-23-000028 · wf-form4_167701404377021.xml · nonDerivative · entry 2

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Charitable Foundation

Disclosed balance after: 213,714

F1 · price: The price reported is a weighted average stock price. Shares were sold between $15.29 and $15.50, inclusive.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 21:14 UTC NEWELL BRANDS INC. NWL · Entity 4339 SaleCommon Stock 107,372 $15.37 $1,650,307.64
Disclosure

SEC source: 0000814453-23-000028 · wf-form4_167701404377021.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 845,631

F1 · price: The price reported is a weighted average stock price. Shares were sold between $15.29 and $15.50, inclusive.

Read SEC document
February 15, 2023 Filed Feb 16, 2023 22:50 UTC DANA Inc DAN · Entity 6 GrantRestricted Stock Units · Derivative 7,982 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-002116 · doc4.xml · derivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,982

Underlying: Common Stock, par value $0.01 · 7,982 shares

Expires not disclosed

F1 · security: Restricted stock units granted pursuant to the Dana Incorporated 2021 Omnibus Incentive Plan.

F2 · derivative.exercise_price: Each restricted stock unit granted represents the right to receive one share of Dana common stock or, at the election of Dana, cash equal to the market value per share. Each restricted stock unit contains dividend equivalent rights.

F3 · derivative.exercise_date: Restricted stock units granted vest in full on the first anniversary date of the grant.

F3 · derivative.expiration_date: Restricted stock units granted vest in full on the first anniversary date of the grant.

Read SEC document
December 30, 2022 Filed Jan 3, 2023 22:08 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 4,589 $6.28 $28,818.92
Disclosure

SEC source: 0001127602-23-000170 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,190

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
December 02, 2022 Filed Dec 5, 2022 21:40 UTC DANA Inc DAN · Entity 6 GrantDividend Equivalent Rights · Derivative 38 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-012314 · doc4.xml · derivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159

Underlying: Common Stock, par value $0.01 · 38 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

Read SEC document
September 30, 2022 Filed Oct 3, 2022 20:15 UTC ICAHN ENTERPRISES L.P. IEP · Entity 3928 Tax withholdingDepositary Units 17,920 $49.77 $891,878.40
Disclosure

SEC source: 0001539497-22-001625 · ownership.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 408,404

F1 · security: Depositary Units representing limited partner interests in Icahn Enterprises L.P.

F2 · kind: Represents the withholding of Depositary Units to satisfy the Reporting Person's tax obligations in connection with the vesting of restricted Depositary Units and accrued dividends. The Reporting Person was granted 239,254 restricted Depositary Units on October 1, 2020 under the Icahn Enterprises L.P. 2017 Long-Term Incentive Plan. 34,179 Depositary Units vested on September 30, 2022.

Read SEC document
September 30, 2022 Filed Oct 3, 2022 20:44 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 4,444 $6.89 $30,619.16
Disclosure

SEC source: 0001127602-22-023263 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,601

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
September 14, 2022 Filed Sep 15, 2022 20:17 UTC NEWELL BRANDS INC. NWL · Entity 4339 SaleCommon Stock 10,000 $17.10 $171,000.00
Disclosure

SEC source: 0000814453-22-000118 · wf-form4_166327303900038.xml · nonDerivative · entry 4

ICAHN BRETT · CIK 0001387184 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Charitable Foundation

Disclosed balance after: 240,000

F3 · price: The price reported is a weighted average stock price. Shares were sold between $17.00 and $17.18, inclusive.

Read SEC document
September 14, 2022 Filed Sep 15, 2022 20:17 UTC NEWELL BRANDS INC. NWL · Entity 4339 SaleCommon Stock 71,304 $16.89 $1,204,324.56
Disclosure

SEC source: 0000814453-22-000118 · wf-form4_166327303900038.xml · nonDerivative · entry 3

ICAHN BRETT · CIK 0001387184 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 953,003

F2 · price: The price reported is a weighted average stock price. Shares were sold between $16.70 and $17.18, inclusive.

Read SEC document
September 13, 2022 Filed Sep 15, 2022 20:17 UTC NEWELL BRANDS INC. NWL · Entity 4339 SaleCommon Stock 150,000 $17.51 $2,626,500.00
Disclosure

SEC source: 0000814453-22-000118 · wf-form4_166327303900038.xml · nonDerivative · entry 2

ICAHN BRETT · CIK 0001387184 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Charitable Foundation

Disclosed balance after: 250,000

F1 · price: The price reported is a weighted average stock price. Shares were sold between $17.19 and $17.71, inclusive.

Read SEC document
September 13, 2022 Filed Sep 15, 2022 20:17 UTC NEWELL BRANDS INC. NWL · Entity 4339 SaleCommon Stock 150,000 $17.51 $2,626,500.00
Disclosure

SEC source: 0000814453-22-000118 · wf-form4_166327303900038.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,024,307

F1 · price: The price reported is a weighted average stock price. Shares were sold between $17.19 and $17.71, inclusive.

Read SEC document
September 02, 2022 Filed Sep 7, 2022 20:45 UTC DANA Inc DAN · Entity 6 GrantDividend Equivalent Rights · Derivative 44 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010139 · doc4.xml · derivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121

Underlying: Common Stock, par value $0.01 · 44 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.